Schmitz et al. (2012)

Summary of novel genes

Entity Tier 1 genes Tier 2 genes
BL 4 16
DLBCL 2 3
--- config: sankey: showValues: true linkColor: target width: 300 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, BL Tier 1, 4 This study, BL Tier 2, 16 Other BL studies, BL Tier 1, 29 Other BL studies, BL Tier 2, 157

Novel genes reported in this study

New gene BL tier DLBCL tier
C16orf48 2
DDX3X 1 1
DHCR7 2
ELP2 2
EXOSC6 2
FLYWCH1 2
FOXO1 1 1
GTSE1 2
ID3 1 2
KANK2 2
MKI67 2
MYO18A 2
NCOR2 2 2
PCBP1 2 2
PDCD11 2
TCF3 1
TOP2A 2
WDR90 2
WHAMM 2
YY1AP1 2

Details

Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics.” Nature 490 (7418): 116–20. https://doi.org/10.1038/nature11378.

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.